Debate Ends Over Chloroquine as France Officially Sanctions Usage – Trustnodes

Debate Ends Over Chloroquine as France Officially Sanctions Usage


Days after beginning a large scale double blinded trial, the so called gold standard, France has now reached the conclusion chloroquine is recommended to treat corona.

Speaking at a news conference, Jérôme Salomon (pictured), France’s director general of health, said the officially sanctioned prescriptions of chloroquine to treat corona “allows a temporary authorization to allow certain patients with coronavirus to benefit from this therapeutic route.”

Doctors in France now will finally be able to treat patients with Didier Raoult, a renown doctor that specializes in infectious diseases, announcing new clinical results that show out of 80 patients treated with chloroquine, 78 recovered within 5 days.

That’s considerably more than the usual 14 days and for some it can go up to 28 days if they recover at all.

The Minister of Health, Olivier Véran, further said on Thursday that doctors can now prescribe chloroquine both in hospital and for home usage:

“Hydroxychloroquine and the combination of lopinavir / ritonavir may be prescribed, dispensed and administered under the responsibility of a doctor to patients affected by Covid-19, in the healthcare establishments which take charge of them, as well as for the continuation of their treatment if their condition allows it and with the authorization of the initial prescriber, at home”.

In America considerable politics has developed over chloroquine, but New York should be out with the results on Monday which may lead to a US wide sanctioned usage of treatment.

In UK the government has prohibited its use outside of trial, but that position is probably untenable now as they have to explain why they are not treating patients as France is doing.

The hope is that once general treatment is given, and preferably early treatment, this situation can be contained as in South Korea or in China or in much of Asia.

Thus they’ll relax the draconian restrictions that have led to supermarkets running out of food even in the nice neighborhoods of London.

A return to normality should then stabilize prices for stocks or cryptos, both of which were on a bull run of sorts before the mass curfews.


Comments (13)

  1. 뭔말인지 하나도 못알아듣겠구만

  2. The study being cited was done by a person who committed fraud in scientific papers before and who badly fudged the results of this study.

  3. I take it anyway for rhumatoid arthritis,,

  4. This is taking away the from people who have lupus and actually cutting or no longer providing them with there medicine. This is not a definite for this situation.

    1. This is LITERALLY not even true. There was CONCERN that it MAY happen….it did not ACTUALLY happen. Fake news….

    2. Do you have any evidence that lupus patients don’t have access? I highly doubt that that is the case

  5. Trust the British to impose such a negative regulation on their population. The politicians are so self-righteous there they are not SERVING the population but RULING them. I have experienced it for a few years working as a medical doctor in the NHS where often the same applies to doctors.

  6. Demorou ! / /
    “The patients cannot sleep beside the windows at home”.
    Take a look at “Van Gogh’s” bed room !
    He leaved sick all the time, because this.

  7. Why does this article claim it was a “double blinded” trial when the study which is even linked to in the article, does not show this to be the case?

    1. Theres a study and there is also a trial, those are two different things.

    2. Need to ask for a copy of how the study was done. Also was it peered reviewed.

  8. The debate only started back then. There is still not proof of its effectiveness. If more than very mildly effective, we would have know by now. People looking for “alternative realitities” keep deluding themselves and others.

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>